MT
Mikko Tapani Kemppainen
About Mikko Tapani Kemppainen
Data last updated:
Mikko Tapani Kemppainen is a Director at Finorion Pharma India Private Limited (since 2025). The company operates in Pharma. Finorion Pharma India Private Limited reported revenue of ₹38.28 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Finorion Pharma India Private Limited U74120MH2011PTC225361 | Director | 24 Apr 2025 | 2011 | ₹38.28 Cr (FY 2025) | Active |
Board colleagues of Mikko Tapani Kemppainen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Johanna Linnea Pakkanen | 07320123 | Finorion Pharma India Private Limited | Director |
| Olli Heikki Huotari | 05119036 | Finorion Pharma India Private Limited | Director |
| Pekka Juhani Kankaanpaa | 11048805 | Finorion Pharma India Private Limited | Director |
| Rene Kristian Lindell | 10717452 | Finorion Pharma India Private Limited | Director |
| Samrudhi Mangesh Utturkar | 08162610 | Finorion Pharma India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mikko Tapani Kemppainen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mikko Tapani Kemppainen
Mikko Tapani Kemppainen currently holds 1 directorship: Finorion Pharma India Private Limited (Director, since 24 Apr 2025, revenue ₹38.28 Cr (FY 2025)).
Mikko Tapani Kemppainen was first appointed on 24 Apr 2025 as Director at Finorion Pharma India Private Limited.
The current boards of Mikko Tapani Kemppainen's companies include Johanna Linnea Pakkanen (Finorion Pharma India Private Limited), Olli Heikki Huotari (Finorion Pharma India Private Limited), Pekka Juhani Kankaanpaa (Finorion Pharma India Private Limited), Rene Kristian Lindell (Finorion Pharma India Private Limited), Samrudhi Mangesh Utturkar (Finorion Pharma India Private Limited).